PNMA8A
Paraneoplastic antigen-like protein 8A
Also known as: FLJ10781, KIAA1183L, PNM8A_HUMAN, PNMAL1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q86V59
- Gene
- PNMA8A
- Ensembl
- ENSG00000182013
- Chromosome
- 19
- Canonical length
- 439 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Nuclear bodies,Cytosol
OverviewNCBI Gene
No narrative summary is available for PNMA8A in this catalog release; identity and structured annotations are shown without generated factual claims.
Canonical amino-acid sequenceUniProt
439 residues, UniProt reviewed canonical sequence.
>Q86V59|PNMA8A
1 MSKTMAMNLL EDWCRGMEVD IHRSLLVTGI PEDCGQAEIE ETLNGVLSPL GPYRVLNKIF
61 VREENVKAAL IEVGEGVNLS TIPREFPGRG GVWRVVCRDP TQDAEFLKNL NEFLDAEGRT
121 WEDVVRLLQL NHPTLSQNQH QPPENWAEAL GVLLGAVVQI IFCMDAEIRS REEARAQEAA
181 EFEEMAAWAL AAGRKVKKEP GLAAEVGSAL KAETPNNWNA TEDQHEPTKP LVRRAGAKSR
241 SRRKKQKKNS RQEAVPWKKP KGINSNSTAN LEDPEVGDAE SMAISEPIKG SRKPCVNKEE
301 LALKKPMAKC AWKGPREPPQ DARAEAESPG GASESDQDGG HESPPKKKAV AWVSAKNPAP
361 MRKKKKVSLG PVSYVLVDSE DGRKKPVMPK KGPGSRREAS DQKAPRGQQP AEATASTSRG
421 PKAKPEGSPR RATNESRKVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PNMA8A can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.58
- Highest tissue expression
- 76 nTPM
Expression across tissuesHPA
Tissue
- cerebral cortex: 76 nTPM
- hypothalamus: 66 nTPM
- cerebellum: 55 nTPM
- basal ganglia: 53 nTPM
- amygdala: 41 nTPM
- hippocampal formation: 36 nTPM
Single-cell type
- other brain neurons: 44 nCPM
- corticotrophs: 43 nCPM
- brain inhibitory neurons: 35 nCPM
- differentiating spermatogonia: 34 nCPM
- retinal pigment epithelial cells: 34 nCPM
- late primary spermatocytes: 32 nCPM
Immune cell
- basophil: 0.6 nTPM
- naive CD8 T-cell: 0.6 nTPM
- memory B-cell: 0.2 nTPM
- memory CD8 T-cell: 0.2 nTPM
- neutrophil: 0.1 nTPM
- NK-cell: 0.1 nTPM
Brain region
- hypothalamus: 133 nTPM
- cerebral cortex: 130 nTPM
- basal ganglia: 113 nTPM
- pons: 94 nTPM
- white matter: 89 nTPM
- thalamus: 84 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.92
- gnomAD pLI
- 0
- DepMap mean gene effect
- 0.03
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
Protein domainsUniProt · Pfam · InterPro
- Paraneoplastic antigen Ma
- Paraneoplastic antigen Ma-like, N-terminal domain
- PNMA N-terminal RRM-like domain
- Paraneoplastic antigen-like protein 8A, C-terminal
- Paraneoplastic antigen 8A protein
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PNMA8A as an antibody target. Whether an autoantibody or antibody against PNMA8A could matter depends on whether native PNMA8A is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PNMA8A is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PNMA8A as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...